Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
September 15, 2003
- METI Wants \3 Bil. to Support Health Services Industry
September 15, 2003
- NEW PRODUCTS
September 15, 2003
- Korosho to Submit Bill for "Basic Pharmaceutical Research Institute"
September 15, 2003
- Financial Results in 1st Quarter
September 15, 2003
- Healthcare Associations to Survey Lawmakers on Social Security
September 15, 2003
- Revised Hypertension GL to Include Major Changes in Drug Therapy: Dr Saruta
September 15, 2003
- REGULATORY NEWS IN BRIEF
September 15, 2003
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
September 15, 2003
- Kyowa Hakko Steps Up Patient Education Activities for Nocturnal Enuresis
September 15, 2003
- OTC NEWS IN BRIEF
September 15, 2003
- Fujisawa Establishes Centralized Drug Info Collection System
September 15, 2003
- DIAGNOSTIC NEWS IN BRIEF
September 15, 2003
- Sankyo Licenses Olmesartan to Pfizer
September 15, 2003
- MEDICAL DEVICE NEWS IN BRIEF
September 15, 2003
- Asahi Kasei Pharma to Specialize in Brain/CNS, Urology, Bones
September 8, 2003
- Takara Bio Succeeds in Enhancing Production of Activated Lymphocytes
September 8, 2003
- CROs Prefer Experienced People Over New Grads: Survey
September 8, 2003
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
September 8, 2003
- BUSINESS NEWS IN BRIEF
September 8, 2003
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…